Innovation is happening. Right here.

Fitzsimons Innovation Community is a sprawling campus of leading-edge laboratory workspace where innovative health and life sciences companies of all sizes take their research to the next level to cure diseases, save lives, and improve care.

Smart, inclusive, forward-thinking, and highly educated people lead life sciences innovation in Colorado, the Hub for Health Impact. Together, we welcome life sciences organizations looking to call Colorado home and to collaborate with a robust community already in on the secret: the health and life sciences industry in Colorado is strong and making a global impact on the future of health.

Move in, and build your vision here—today.

The emphasis is on Community

We called it a community for a reason. From the board of directors to the newest company on campus, everyone at Fitzsimons Innovation Community knows that easy access to collaboration has direct results on success. From idea incubation to final-product manufacturing, your end-to-end innovation can come alive right here on our campus. All that Colorado sunshine is just a bonus.

Community

Cutting-edge discoveries in action

62%

Companies Hiring

Fitzsimons Innovation Community member companies are thriving. 62% of companies added employees to their workforce.

75%

Companies Fundraising

Most Fitzsimons Innovation Community member companies are actively involved in fundraising to power their progress.

16+

New Innovations

Fitzsimons Innovation Community member companies introduced more than 16 new innovations to the market in 2023.

$116M

Capital Raised

Last year, Fitzsimons Innovation Community member companies attracted more than $116M in investments to support R&D, prepare for clinical trials, accelerate commercialization, and retain or recruit talent.

75%

Companies with Discoveries

Fitzsimons Innovation Community member companies made news with major breakthrough discoveries last year. Areas included molecular biology, pharmaceuticals, medical device, research tools, cell and gene therapy, material science, and diagnostics.

50%

Companies Forging Strategic Partnerships

Fitzsimons Innovation Community member companies forged strategic partnerships for business collaboration, legal services, and venture capital opportunities.

*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2023)

A heritage of healthcare and innovation

Fitzsimons Innovation Community stands on the grounds that once held the Fitzsimons Army Hospital, where soldiers returning from World War I were treated. The Colorado high altitude has always been a destination for advancements in lung treatment, and 100 years ago, soldiers sought cures for tuberculosis and mustard gas exposure right here.

After the Army decommissioned the hospital in the 1990s, ideas for the current University of Colorado Anschutz Medical Campus and Fitzsimons Innovation Community began to percolate. That rich history of discovery, care, and research continues to inspire our vision a century later.

VISION

Our team is on your team

You know best when it comes to your projects, and we know how to keep you up and running with first-class scientific facilities management and community engagement. Our priority is to help you thrive on this campus and we have the proven tools and expertise to make that happen.

Don Larson

Facilities engineer

Erica N. Slaughenhoup

Accounting Specialist

Julie Ehler

Accounting Lead

Lyle Artz

Site manager

Steve VanNurden

PRESIDENT & CEO

Sue Niblo

Senior property manager

Thomas Smith

Vp, finance & operations

“The workspace has been perfect for our projects, but the most impressive thing to me has been the community. We’ve collaborated with researchers from the CU Anschutz Medical Campus, networked with other Fitzsimons Innovation Community members, and bounced ideas off some of the best minds in healthcare. And it’s all contributed to us moving forward in our research.”

Scott Deeter

CEO, InVitria

“I park my car in the morning, and then I never move it until I leave after work. We walk to lunch and meetings and take advantage of the outdoor space as much as we can during the day. Work-life balance happens right on campus.”

Kristin Nixon

President, PhosphoSolutions

Community

Fitzsimons Innovation Community News

VIEW ALL NEWS

News | Dec 02, 2024

Fitzsimons Innovation Community CEO Announces Retirement

Fitzsimons Innovation Community President and CEO Steve VanNurden will retire at the end of 2024. After nearly 35 years as a life sciences industry leader, VanNurden leaves a lasting impact on the Community, on the adjacent University of Colorado (CU) Anschutz Medical Campus where he also serves as Associate Vice Chancellor of Biotechnology, and on Colorado’s life sciences ecosystem.

News | Nov 12, 2024

Fitzsimons Innovation Community Selected as New Home for RefinedScience

Fitzsimons Innovation Community, an integrated campus of leading-edge facilities for innovative health and life sciences companies, announces RefinedScience, a Colorado high-tech biosciences company working to transform precision drug development, has selected the Community for its Colorado headquarters. To accelerate its path to market, RefinedScience will transition from The Foundry, a CU Innovations incubator housed in Bioscience 1, to permanent lab and office space in Bioscience 3 at Fitzsimons Innovation Community.

News | Oct 28, 2024

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner

Colorado Inno Awards has selected Lohocla Research Corp as one of its 10 trailblazers making waves in the Colorado innovation ecosystem. Lohocla received FDA clearance in March for the first-in-human trials of a drug, Nezavist, intended to treat alcohol use disorder and craving. The company also received similar FDA clearance in October 2023 to move forward with Phase 1 trials of another drug it developed, Kindolor, to treat chronic pain.

News | Oct 28, 2024

Aurora mayor eyes redevelopment as catalyst to city's success

Mike Coffman, City of Aurora Mayor and Fitzsimons Innovation Community Board Member, gave his annual State of the City address last week with a focus on maximizing the opportunity that exists with ongoing development of the CU Anschutz Medical Campus and the Fitzsimons Innovation Community.

News | Oct 28, 2024

Steve VanNurden Joins Denver Dealmakers Hall of Fame

Steve VanNurden, Fitzsimons Innovation Community President and CEO, was inducted into the Denver Dealmakers Hall of Fame, recognizing a class of dealmakers that has made an often-groundbreaking impact on their organizations, industries, and the region over the course of decades in business.

News | Oct 28, 2024

Here's How Denver Stacks up at Landing Company Headquarters

Metro Denver EDC hosted national site selectors to learn about Colorado’s competitive advantage. Adams County was highlighted for its opportunity to gain companies by providing data that shows how it is a more affordable community directly adjacent to the city of Denver.

News | Oct 04, 2024

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series

With over three decades in biotech, Max Colao, CEO of OncoVerity, is at the forefront of personalized cancer treatment. In this compelling interview with Pharmaceutical Executive, Colao discusses his journey from industry giants to leading the startup OncoVerity in revolutionizing oncology care through computational biology and machine learning.

News | Oct 04, 2024

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor

Brian Freed, Ph.D., Co-Founder & Chief Science Officer, RheumaGen, Executive Director, ClinImmune, and Professor of Medicine, University of Colorado will be recognized by the American Society of Histocompatibility & Immunogenetics (ASHI) with their highest honor.

News | Sep 18, 2024

GelSana Shares Vision for Innovative Would Care Solutions with Pharmaceutical Executive

In an interview with Pharmaceutical Executive, Melissa Krebs, Ph.D., the CEO and founder of GelSana, discusses her journey in developing novel biomaterials that aim to revolutionize the $78 billion wound care market

News | Sep 18, 2024

EnteroTrack: Tiny Capsule Could Be Game Changer in Gut Health

Denver’s 9News recently profiled a biotech entrepreneur leveraging a health innovation developed at Fitzsimons Innovation Community. Robin Shandas, founder and CEO of EnteroTrack, developed the swallowable capsule that collects microbiome samples. Using the capsule, UC Denver graduate student Alex Gregorian founded an early stage startup, BioWell, to make gut health insights more accessible.

Phone. Address. Email.

Want to stay on top of what’s happening on campus?

Sign up for regular updates from Fitzsimons Innovation Community.

Thank you for subscribing!